JB Chemicals & Pharmaceuticals Ltd. has acquired a number of brands in the probiotics, therapeutic nutraceuticals and reproductive health markets from Sanzyme, in a transaction valued at INR6.28bn ($83.4m). The deal is expected to be completed within the next two weeks following customary closing formalities, having been signed off at a 25 January board meeting.
“Leading brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-leo and Gynogen will now be part of the JBCPL franchise,” JB Chemicals said, adding that Sanzyme